I don't know much about psilocybin, and I'll admit I was initially underwhelmed by this post TH announcement (was so sure that it was going to be dealers licence related) but your informative posts have certainly educated me and other holders.
To now have one of the largest psilocybin inventories in Canada, with enough to take us through the extensive Phase 2 and P3 of the Halucenex trials really re-risks this major acquisition.
From what I can read online, other global trials in use of psilocybin for treatment of mental health issues have been very successful.
@MentalAs shared a great article, well worth a read
Now very content with the Halucenex acquisition, certainly opens up a massive new market for CPH. For the doubters - this is why we pay top dollar for strategic advisors like Bruce Linton.
Onwards and upwards CPH fans!
CPH Price at posting:
18.0¢ Sentiment: Buy Disclosure: Held